ArticleExpert review of precision medicine and drug development2018

The genetic risk of second cancers: should the therapy for acute lymphoblastic leukemia be individualized according to germline genetic makeup?

Kathleen E A Felton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.